[
  {
    "ts": null,
    "headline": "Thermo Fisher: Growth Acceleration And Margin Expansion Should Drive The Upside",
    "summary": "Thermo Fisher saw accelerating revenue growth in pharma/biotech, AI-driven cost efficiencies, and attractive valuations. See here for more on TMO stock.",
    "url": "https://finnhub.io/api/news?id=a3ab8364eb89428c78520196198cbcfceba865db4b0b9752a134e6cdccef563b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754954454,
      "headline": "Thermo Fisher: Growth Acceleration And Margin Expansion Should Drive The Upside",
      "id": 136313870,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413606459/image_1413606459.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "Thermo Fisher saw accelerating revenue growth in pharma/biotech, AI-driven cost efficiencies, and attractive valuations. See here for more on TMO stock.",
      "url": "https://finnhub.io/api/news?id=a3ab8364eb89428c78520196198cbcfceba865db4b0b9752a134e6cdccef563b"
    }
  },
  {
    "ts": null,
    "headline": "Avantor Surges As Activist Investor Takes Aim At 'Self-Inflicted' Issues",
    "summary": "Avantor surged Monday as Engine Capital digs in to reverse what the activist investor says are years of \"extreme\" value destruction.",
    "url": "https://finnhub.io/api/news?id=6922bddc1aedc97410958eb617d787be0791c9299712ace11d35c5465c45d3fc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754921295,
      "headline": "Avantor Surges As Activist Investor Takes Aim At 'Self-Inflicted' Issues",
      "id": 136294342,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Avantor surged Monday as Engine Capital digs in to reverse what the activist investor says are years of \"extreme\" value destruction.",
      "url": "https://finnhub.io/api/news?id=6922bddc1aedc97410958eb617d787be0791c9299712ace11d35c5465c45d3fc"
    }
  },
  {
    "ts": null,
    "headline": "Allergy Diagnostics Market Trends Analysis Report 2025-2030 | Rising Allergy Rates, Diagnostic Innovations, and Government Investments Drive Market Growth",
    "summary": "The global allergy diagnostics market, poised to reach USD 11.63 billion by 2030, is expanding at a CAGR of 10.39% from 2025. The rise in allergies highlights the need for precise diagnostics. Major players like Thermo Fisher and Siemens are innovating to meet demand. Key growth regions include North America and Asia Pacific. Allergy Diagnostics Market Allergy Diagnostics Market Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The \"Allergy Diagnostics Market Size, Share & Trends Analysis Report By Prod",
    "url": "https://finnhub.io/api/news?id=f58866998217d28c6888e888f1f4d9169feb1304953e7fcbdc985ae5d04174a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754918880,
      "headline": "Allergy Diagnostics Market Trends Analysis Report 2025-2030 | Rising Allergy Rates, Diagnostic Innovations, and Government Investments Drive Market Growth",
      "id": 136294343,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "The global allergy diagnostics market, poised to reach USD 11.63 billion by 2030, is expanding at a CAGR of 10.39% from 2025. The rise in allergies highlights the need for precise diagnostics. Major players like Thermo Fisher and Siemens are innovating to meet demand. Key growth regions include North America and Asia Pacific. Allergy Diagnostics Market Allergy Diagnostics Market Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The \"Allergy Diagnostics Market Size, Share & Trends Analysis Report By Prod",
      "url": "https://finnhub.io/api/news?id=f58866998217d28c6888e888f1f4d9169feb1304953e7fcbdc985ae5d04174a1"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Receives FDA Approval for NGS-Based Companion Diagnostic for New Non-Small Cell Lung Cancer Treatment",
    "summary": "CARLSBAD, Calif., August 11, 2025--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients who may be candidates for HERNEXEOS® (zongertinib tablets), a tyrosine kinase inhibitor (TKI), developed by Boehringer Ingelheim. The test allows clinicians and pathologists to assess if non-small cell lung cancer (NSCLC) tumors harbor human epid",
    "url": "https://finnhub.io/api/news?id=35c6045a8d8e7c857b4ba1aa4f14801f15de04f123c69c30675e040578c5ca08",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754915400,
      "headline": "Thermo Fisher Receives FDA Approval for NGS-Based Companion Diagnostic for New Non-Small Cell Lung Cancer Treatment",
      "id": 136294344,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "CARLSBAD, Calif., August 11, 2025--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients who may be candidates for HERNEXEOS® (zongertinib tablets), a tyrosine kinase inhibitor (TKI), developed by Boehringer Ingelheim. The test allows clinicians and pathologists to assess if non-small cell lung cancer (NSCLC) tumors harbor human epid",
      "url": "https://finnhub.io/api/news?id=35c6045a8d8e7c857b4ba1aa4f14801f15de04f123c69c30675e040578c5ca08"
    }
  }
]